Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : John, Mike & Tom's Wild World of Stocks -- Ignore unavailable to you. Want to Upgrade?

To: John Pitera who wrote (1216)	6/6/2000 7:30:00 PM
From: accountclosed	Read Replies (1) \| Respond to of 2850

thanks, john. nice article.

To: John Pitera who wrote (1216)	6/7/2000 9:11:00 AM
From: wlheatmoon	Read Replies (2) \| Respond to of 2850

You want MSFT and CSCO of the decade and more to come? I'd bet that the genomics have that potential. As I have stated before, the biggies with potential drugs are MLNM, HGSI, and INCY. CRA has information and that's harder to value. I believe these are potential huge winners in the next decade. When all is said and done, health care and living longer is what we all want. Another way to play these may be to buy biotech mutual funds. I have some fidelity biotechs, but I don't really know how much they have of these companies. The idea is to buy a basket of these and you'll have some outrageous winners and losers. The winners will make the losers look like nice tax write-offs. The pharmaceutical giants will be involved in this arena as well. They'll either form alliances or buy these companies. Internal research would take too much time and be too expensive. The HGSI, MLNM, INCY have a leg up on them and the information they have is worth a lot of money either to themselves or to some giant pharmaceutical companies. mike